Compound Profile Scientific & Efficacy Data C 194 H 312 N 54 O 59 S 2 Molecular Formula 4409 g/mol Molecular Weight 159-195 hours (~7-8 days) Half-Life ~100% (subcutaneous) Bioavailability 1415456-99-3 CAS # 171397054 PubChem ID Developed By 2021 Thomas Kruse Novo Nordisk Primary Benefits Exceptional appetite suppression through dual amylin and calcitonin receptor activation, creating powerful and sustained satiety signals Impressive 10-15% weight loss alone, or 20%+ when combined with semaglutide in the CagriSema combination Uniquely designed to complement GLP-1 medications through an independent mechanism, dramatically enhancing results when combined Amino Acid Sequence Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 (acylated with C18 diacid via gamma-Glu linker) Dosing How much do I take
PEPTIDES: BPC-157 & TB-500 in The Colony TX Accelerate Recovery, Support Healing, Enhance Wellness At Stonebridge Medical, were excited to offer cutting-edge Peptide Therapy in The Colony TX , including our exclusive Wolverine Stack , to help patients recover faster, heal smarter, and elevate their overall vitality
Always consult a qualified medical provider
ICD-10-CM Guidelines (FY2026) All diabetes mellitus coding is governed by ICD-10-CM Official Guidelines for Coding and Reporting FY2026, Section I.C.4 (Endocrine, Nutritional, and Metabolic Diseases)
By gradually tapering off the medication with your physicians guidance, you can better manage these changes and maintain your health and wellness goals
